| Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 N Drayman, JK DeMarco, KA Jones, SA Azizi, HM Froggatt, K Tan, ... Science 373 (6557), 931-936, 2021 | 187 | 2021 |
| Designing and building oncolytic viruses J Maroun, M Muñoz-Alía, A Ammayappan, A Schulze, KW Peng, ... Future virology 12 (4), 193-213, 2017 | 143 | 2017 |
| Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro N Drayman, KA Jones, SA Azizi, HM Froggatt, K Tan, NI Maltseva, S Chen, ... BioRxiv, 2020.08. 31.274639, 2020 | 42 | 2020 |
| Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins MÁ Muñoz-Alía, RA Nace, L Zhang, SJ Russell Cell Reports Medicine 2 (4), 2021 | 41 | 2021 |
| Measles virus genetic evolution throughout an imported epidemic outbreak in a highly vaccinated population MÁ Muñoz-Alía, R Fernández-Muñoz, JM Casasnovas, R Porras-Mansilla, ... Virus research 196, 122-127, 2015 | 32 | 2015 |
| Antigenic drift defines a new D4 subgenotype of measles virus MÁ Muñoz-Alía, CP Muller, SJ Russell Journal of virology 91 (11), 10.1128/jvi. 00209-17, 2017 | 25 | 2017 |
| Probing morbillivirus antisera neutralization using functional chimerism between measles virus and canine distemper virus envelope glycoproteins MA Muñoz-Alía, SJ Russell Viruses 11 (8), 688, 2019 | 20 | 2019 |
| Oncolytic measles virotherapy and opposition to measles vaccination SJ Russell, D Babovic-Vuksanovic, A Bexon, R Cattaneo, D Dingli, ... Mayo Clinic Proceedings 94 (9), 1834-1839, 2019 | 19 | 2019 |
| Retargeted and stealth-modified oncolytic measles viruses for systemic cancer therapy in measles immune patients ES Bah, RA Nace, KW Peng, MÁ Muñoz-Alía, SJ Russell Molecular cancer therapeutics 19 (10), 2057-2067, 2020 | 18 | 2020 |
| MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum MÁ Muñoz-Alía, RA Nace, A Tischer, L Zhang, ES Bah, M Auton, ... PLoS pathogens 17 (2), e1009283, 2021 | 15 | 2021 |
| Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses MA Munoz-Alia, CP Muller, SJ Russell PLoS One 13 (2), e0192245, 2018 | 15 | 2018 |
| Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine KW Peng, T Carey, P Lech, R Vandergaast, MÁ Muñoz-Alía, ... Vaccine 40 (15), 2342-2351, 2022 | 13 | 2022 |
| Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies MA Muñoz-Alía, JM Casasnovas, ML Celma, J Carabaña, PB Liton, ... Virus research 236, 30-43, 2017 | 12 | 2017 |
| Subacute Sclerosing Panencephalitis and Other Lethal Encephalitis Caused by Measles Virus Infection: Pathogenesis and New Approaches to Treatment BM Duque, A Martin-Cortes, A Serrano-Pardo, MA Muñoz-Alia, ... Non-Flavivirus Encephalitis, 157, 2011 | 4 | 2011 |
| Pathogenic measles viruses cannot evolve to bypass vaccine-induced neutralizing antibodies MÁ Muñoz-Alía, RA Nace, L Zhang, SJ Russell BioRxiv, 2020.10. 22.351189, 2020 | 3 | 2020 |
| Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical … MÁ Muñoz-Alía, RA Nace, B Balakrishnan, L Zhang, N Packiriswamy, ... Mbio, e02928-23, 2024 | 1 | 2024 |
| A measles virus vector pseudotyped with CD46-retargeted canine distemper envelope achieves oncolysis in the presence of measles-immune human serum MA Munoz-Alia, RA Nace, SJ Russell MOLECULAR THERAPY 28 (4), 588-588, 2020 | 1 | 2020 |
| Canine distemper virus hemagglutinin and fusion polypeptides SJ Russell, MAM Alia US Patent App. 17/767,970, 2024 | | 2024 |
| In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector K Krotova, GN Nenavath, N Packiriswamy, R Vandergaast, M Moy, ... Blood 142, 767, 2023 | | 2023 |
| Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses … MÁ Muñoz-Alía, RA Nace, B Balakrishnan, L Zhang, N Packiriswamy, ... bioRxiv, 2022 | | 2022 |
